Figure 1From: Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: A cost effectiveness study Decision tree for the economic evaluation of paliperidone ER in the treatment of patients with schizophrenia experiencing an acute exacerbation. Back to article page